Exelixis | EXEL - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
Acadia Pharmaceuticals USD 8.33M 86K 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
AstraZeneca USD 73M 62M 2026-03
Bayer EUR 169M 39M 2025-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Cytokinetics USD 11.02M 448K 2026-03
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 16.13M 1.3M 2026-03
Genmab DKK 25M 8M 2025-06
Glaxosmithkline GBP 22M 4M 2026-03
Incyte USD 33.69M 2.93M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
MacroGenics USD 1.55M 26K 2026-03
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 60M 54M 2026-03
Takeda JPY 87.87B 43.48B 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Xencor USD 6.2M 338K 2025-12